Divergent targets of glycolysis and oxidative phosphorylation result in additive effects of metformin and starvation in colon and breast cancer

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Marini, Cecilia ^a   Bianchi, Giovanna ^b   Buschiazzo, Ambra ^c   Ravera, Silvia ^d   Martella, Roberto ^b   Bottoni, Gianluca ^c   Petretto, Andrea ^b   Emionite, Laura ^c   Monteverde, Elena ^c   Capitanio, Selene ^c   Inglese, Elvira ^b   Fabbi, Marina ^c   Bongioanni, Francesca ^c   Garaboldi, Lucia ^c   Bruzzi, Paolo ^c   Orengo, Anna Maria ^c   Raffaghello, Lizzia ^b   Sambuceti, Gianmario ^c  

^a CNR   (Italy)

^b G GASLINI INSTITUTE   (Italy)

^c UNIVERSITY OF GENOA   (Italy)

^d UNIVERSITY OF GENOA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; METFORMIN; REACTIVE OXYGEN METABOLITE; STAUROSPORINE;

ANIMAL; BAGG ALBINO MOUSE; BIOLOGICAL MODEL; BREAST TUMOR; CELL PROLIFERATION; COLON TUMOR; DRUG EFFECTS; ENERGY METABOLISM; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GLYCOLYSIS; HUMAN; METABOLISM; OXIDATIVE PHOSPHORYLATION; PATHOLOGY; TUMOR CELL LINE;

ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; COLONIC NEOPLASMS; ENERGY METABOLISM; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GLUCOSE; GLYCOLYSIS; HUMANS; METFORMIN; MICE, INBRED BALB C; MODELS, BIOLOGICAL; OXIDATIVE PHOSPHORYLATION; REACTIVE OXYGEN SPECIES; STAUROSPORINE;

EID: 84955443998     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep19569     Document Type: Article

References (39)

1. Vander Heiden, M., Cantley, L. C. & Thompson, C. B. Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science 324, 1029-1033 (2009).
2. Macheda, M. L., Rogers, S. & Best, J. D. Molecular and cellular regulation of glucose transporter (GLUT) proteins in cancer. J. Cell Physiol. 202, 654-662 (2005).
3. Vleugel, M. M. et al. Differential prognostic impact of hypoxia induced and diffuse HIF-1alpha expression in invasive breast cancer. J. Clin. Pathol. 58, 172-177 (2005).
4. Lee, C. et al. Fasting cycles retard growth of tumors and sensitize a range of cancer cell types to chemotherapy. Sci. Transl. Med. 4, 124-127 (2012).
5. Hanahan, D. & Weinberg, R. A. Hallmarks of cancer: the next generation. Cell 144, 646-74 (2011).
6. Trachootham, D., Alexandre, J. & Huang, P. Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach ? Nat. Rev. Drug. Discov. 8, 579-591 (2009).
7. Diehn, M. et al. Association of reactive oxygen species levels and radioresistance in cancer stem cells. Nature 458, 780-783 (2009).
8. Raffaghello, L. et al. Starvation-dependent differential stress resistance protects normal but not cancer cells against high-dose chemotherapy. Proc. Natl. Acad. Sci. USA 105, 8215-8220 (2008).
9. Madiraju, A. K. et al. Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase. Nature 510, 542-546 (2014).
10. Zhou, G. et al. Role of AMP-activated protein kinase in mechanism of metformin action. J. Clin. Invest. 108, 1167-1174 (2001).
11. Shaw, R. J. et al. The kinase LKB1 mediates glucose homeostasis in liver and therapeutic effects of metformin. Science 310, 1642-1646 (2005).
12. Owen, M. R., Doran, E. & Halestrap, A. P. Evidence that metformin exerts its anti-diabetic effects through inhibition of Complex 1 of the mitochondrial respiratory chain. Biochem. J. 348, 607-614 (2000).
13. Viollet, B. et al. Cellular and molecular mechanisms of metformin: an overview. Clin. Sci. 122, 253-270 (2012).
14. Birsoy, K., Sabatini, D. M. & Possemato, R. Untuning the tumor metabolic machine: targeting cancer metabolism: a bedside lesson. Nat. Med. 18, 1022-1023 (2012).
15. Zordoky, B. N., Bark, D., Soltys, C. L., Sung, M. M. & Dyck, J. R. The anti-proliferative effect of metformin in triple-negative MDAMB-231 breast cancer cells is highly dependent on glucose concentration: implications for cancer therapy and prevention. Biochim. Biophys. Acta 1840, 1943-1957 (2014).
16. Hadad, S. M., Hardie, D. G., Appleyard, V. & Thompson, A. M. Effects of metformin on breast cancer cell proliferation, the AMPK pathway and the cell cycle. Clin. Transl. Oncol. 16, 746-752 (2014).
17. El-Mir, M. Y. et al. Dimethylbiguanide inhibits cell respiration via an indirect effect targeted on the respiratory chain Complex I. J. Biol. Chem. 275, 223-228 (2000).
18. Salani, B. et al. Metformin impairs glucose consumption and survival in Calu-1 cells by direct inhibition of hexokinase-II. Sci. Rep. 3, 2070 (2013).
19. Marini, C. et al. Direct inhibition of hexokinase activity by metformin at least partially impairs glucose metabolism and tumor growth in experimental breast cancer. Cell Cycle 12, 3490-3499 (2013).
20. Robey, R. B. & Hay, N. Mitochondrial hexokinases, novel mediators of the antiapoptotic effects of growth factors and Akt. Oncogene 25, 4683-4696 (2006).
21. Vander Heiden, M. G. et al. Growth factors can influence cell growth and survival through effects on glucose metabolism. Mol. Cell. Biol. 21, 5899-5912 (2001).
22. Mithieux, G., Guignot, L., Bordet, J. C. & Wiernsperger, N. Intrahepatic mechanisms underlying the effect of metformin in decreasing basal glucose production in rats fed a high-fat diet. Diabetes 51, 139-143 (2002).
23. Rovetto, M. J., Whitmer, J. T. & Neely, J. R. Comparison of the effects of anoxia and whole heart ischemia on carbohydrate utilization in isolated working rat hearts. Circ. Res. 32, 699-711 (1973).
24. Lambert, A. J. & Brand, M. D. Reactive oxygen species production by mitochondria. Methods. Mol. Biol. 554, 165-181 (2009).
25. Turrens, J. F. Mitochondrial formation of reactive oxygen species. J. Physiol. 552, 335-344 (2003).
26. Paranagama, M. P. et al. Contribution of the FAD and quinone binding sites to the production of reactive oxygen species from Ascaris suum mitochondrial Complex II. Mitochondrion 10, 158-165 (2010).
27. Loschen, G., Flohé, L. & Chance, B. Respiratory chain linked H(2)O(2) production in pigeon heart mitochondria. FEBS Lett. 18, 261-264 (1971).
28. Takeshige, K. & Minakami, S. NADH- and NADPH-dependent formation of superoxide anions by bovine heart submitochondrial particles and NADH-ubiquinone reductase preparation. Biochem. J. 180, 129-135 (1979).
29. Cairns, R. A., Harris, I. S. & Mak, T. W. Regulation of cancer cell metabolism. Nat. Rev. Cancer 11, 85-95 (2011).
30. Meyer, F., Ipaktchi, M. & Clauser. H. Specific inhibition of gluconeogenesis by biguanides. Nature 213, 203-204 (1967).
31. Ota, S. et al. Metformin suppresses glucose-6-phosphatase expression by a Complex I inhibition and AMPK activation-independent mechanism. Biochem. Biophys. Res. Commun. 388, 311-316 (2009).
32. European Pharmacopoeia 5th edition, Directorate for the Quality of Medicines (EDQM), Council of Europe, Strasbourg Cedex, France, Supplement 5.1, 5.2 (2005).
33. Phoenix, K. N., Vumbaca, F. & Claffey, K. P. Therapeutic metformin/AMPK activation promotes the angiogenic phenotype in the ERalpha negative MDA-MB-435 breast cancer model. Breast Cancer Res. Treat. 113, 101-111 (2009).
34. Massollo, M. et al. Metformin temporal and localized effects on gut glucose metabolism assessed using 18F-FDG PET in mice. J. Nucl. Med. 54, 259-266 (2013).
35. Iozzo, P. et al. 18F-FDG assessment of glucose disposal and production rates during fasting and insulin stimulation: a validation study. J. Nucl. Med. 47, 1016-1022 (2006).
36. Patlak, C. S., Blasberg, R. G. & Fenstermacher, J. D. Graphical evaluation of blood-to-brain transfer constants from multiple-time uptake data. J. Cereb. Blood Flow Metab. 3, 1-7 (1983).
37. Cox, J. & Mann, M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteomewide protein quantification. Nat. Biotechnol. 26, 1367-1372 (2008).
38. Marimpietri, D. et al. Combined therapeutic effects of vinblastine and rapamycin on human neuroblastoma growth, apoptosis, and angiogenesis. Clin. Cancer Res. 13, 3977-3988 (2007).
39. Slinker, B. K. The statistics of synergism. J. Mol. Cell. Cardiol. 30, 723-731(1998).